-
1 Comment
Zhejiang AngLiKang Pharmaceutical CO.,LTD is currently in a long term downtrend where the price is trading 10.7% below its 200 day moving average.
From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.
Zhejiang AngLiKang Pharmaceutical CO.,LTD's total revenue sank by 2.7% to $310M since the same quarter in the previous year.
Its net income has increased by 55.4% to $39M since the same quarter in the previous year.
Finally, its free cash flow grew by 49.7% to $45M since the same quarter in the previous year.
Based on the above factors, Zhejiang AngLiKang Pharmaceutical CO.,LTD gets an overall score of 3/5.
Zhejiang AngLiKang Pharmaceutical CO.,LTD. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers chemical raw materials for pharmaceuticals comprising oral cephalosporin antibiotic raw materials, including cephalexin, cefadroxil, cefaclor, and cefadroxil; alpha-keto acid raw materials; inhaled anesthetic raw materials, such as isoflurane and sevoflurane; and anti-androgen intermediates, including finasteride and dutasteride. It also provides chemical agents consisting of anti-infective preparations, such as cefixime and cefadroxil capsules, cefaclor sustained-release tablets, cefaclor granules, and cefalexin capsules; cardiovascular preparations, including levamlodipine besylate and amlodipine besylate tablets, nifedipine sustained-release and sacubitril/valsartan sodium tablets, and measartan potassium and ticagrelor tablets; anesthetic and analgesic preparations, such as sevoflurane inhalation, liprocaine cream, and pregabalin capsules; nephropathy preparations, including compound a-keto acid tablets, levocarnitine oral solutions, and lanthanum carbonate chewable tablets; oryzanol and doxofylline tablets; and other products. In addition, the company offers specialty intermediates, such as plant-derived cholesterol and its derivatives, plant-derived vitamin D3, and plant-derived 25-hydroxyvitamin D3. Further, it provides lyophilized powder injections, steroidal biological products, and plant extracts; penicillin; and active pharmaceutical ingredients (APIs) for respiratory system, digestive system, and pain indications. Additionally, the company engages in biotechnology promotion activities. The company serves pharmaceutical companies, commercial and pharmaceutical distribution companies, chemical and nutritional companies, and feed companies. Zhejiang AngLiKang Pharmaceutical CO.,LTD. was founded in 2001 and is headquartered in Shengzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002940.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
